Mayaro Virus: An Emerging Alphavirus in the Americas
Related Experiment Video
Updated: Jun 14, 2025

Highly Sensitive Assay for Measurement of Arenavirus-cell Attachment
Published on: March 2, 2016
Lily Li Lin Wei1, Rufaro Tom1, Young Chan Kim2,3
1Somerville College, University of Oxford, Woodstock Road, Oxford OX2 6HD, UK.
Abstract:
Mayaro virus (MAYV) is an arbovirus first isolated in Trinidad and Tobago in 1954. MAYV is the causative agent of Mayaro fever, which is characterised by high fever, maculopapular rash, myalgia and arthralgia. The potential for chronic arthralgia is of particular clinical concern. Currently, MAYV outbreaks are restricted to South and Central America, with some cases reported in Africa as well as several imported cases in Europe. However, in recent years, MAYV has become a growing global concern due to its potential to emerge into urban transmission cycles. Challenges faced with diagnostics, as well as a lack of specific antivirals or licensed vaccines further exacerbate the potential global health threat posed by MAYV. In this review, we discuss this emerging arboviral threat with a particular focus on the current treatment and vaccine development efforts. Overall, MAYV remains a neglected arbovirus due to its limited area of transmission. However, with the potential of its urbanisation and expanding circulation, the threat MAYV poses to global health cannot be overlooked. Further research into the improvement of current diagnostics, as well as the development of efficacious antivirals and vaccines will be crucial to help prevent and manage potential MAYV outbreaks.
Insights
Mayaro virus (MAYV) causes Mayaro fever with symptoms like fever and joint pain. This arbovirus review highlights its growing global threat and the urgent need for better diagnostics and treatments.
Area of Science:
- Arbovirology
- Infectious Diseases
- Public Health
Background:
- Mayaro virus (MAYV) is an arbovirus first identified in 1954, causing Mayaro fever characterized by fever, rash, myalgia, and arthralgia.
- While MAYV outbreaks are currently limited to South and Central America, Africa, and imported cases in Europe, its potential for urban transmission poses a growing global concern.
- Challenges in diagnostics and the absence of specific antivirals or vaccines amplify the global health threat of MAYV.
Purpose of the Study:
- To review the emerging arboviral threat of Mayaro virus (MAYV).
- To focus on current treatment and vaccine development efforts against MAYV.
- To emphasize the need for improved diagnostics, antivirals, and vaccines for MAYV prevention and management.
Main Methods:
- This study is a review of existing literature on Mayaro virus.
- It synthesizes information on MAYV epidemiology, clinical manifestations, and current research.
- Focus is placed on analyzing challenges and advancements in diagnostics, treatments, and vaccine development.
Main Results:
- Mayaro fever presents with acute symptoms, with chronic arthralgia being a significant clinical concern.
- MAYV's potential for urbanization and expanding circulation increases its global health relevance.
- Current diagnostic and therapeutic options for MAYV are limited, underscoring a critical gap in public health preparedness.
Conclusions:
- Mayaro virus, despite being historically neglected due to limited transmission areas, represents a significant and growing global health threat.
- The potential for urban transmission cycles necessitates increased attention and research.
- Advancements in diagnostics, alongside the development of effective antivirals and vaccines, are crucial for mitigating the impact of potential MAYV outbreaks.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Viral Mutations
What are Viruses?
Retrovirus Life Cycles
Viral Recombination
Retroviruses

